Literature DB >> 16845866

Totally implantable venous access ports: a clinical trial comparing percutaneous versus surgical technique.

Cristian Riapisarda1, Raffaele Lanteri, Marco Santangelo, Giovanni Li Destri, Antonio Di Cataldo, Antonio Licata.   

Abstract

Totally implantable venous access ports are valuable instruments for long-term intravenous treatment of patients with cancer, but implantation and use of these devices may be associated with complications. The aim of our study was to compare two implantation techniques in order to establish which one is better for the patient and the surgeon as regards morbidity, surgical time, tolerability, and costs. A prospective study was conducted on a series of 99 patients undergoing implantation of totally implantable venous access ports with surgical cut-down or percutaneous access from January 2000 to June 2004 at the Department of Surgical Sciences, Organ Transplantation and Advanced Technologies. Our experience shows that there are no statistically significant differences between these two techniques in terms of associated morbidity, technical failure, operative time and patient acceptance.

Entities:  

Mesh:

Year:  2006        PMID: 16845866

Source DB:  PubMed          Journal:  Chir Ital        ISSN: 0009-4773


  3 in total

1.  Totally implantable venous access devices - 20 years' experience of implantation in cystic fibrosis patients.

Authors:  T James Royle; Ruth E Davies; Mark X Gannon
Journal:  Ann R Coll Surg Engl       Date:  2008-11       Impact factor: 1.891

Review 2.  Venous cutdown versus the Seldinger technique for placement of totally implantable venous access ports.

Authors:  Charlie C-T Hsu; Gigi N C Kwan; Hannah Evans-Barns; John A Rophael; Mieke L van Driel
Journal:  Cochrane Database Syst Rev       Date:  2016-08-21

3.  Meta-analysis of primary open versus closed cannulation strategy for totally implantable venous access port implantation.

Authors:  Ulla Klaiber; Pascal Probst; Matthes Hackbusch; Katrin Jensen; Colette Dörr-Harim; Felix J Hüttner; Thilo Hackert; Markus K Diener; Markus W Büchler; Phillip Knebel
Journal:  Langenbecks Arch Surg       Date:  2021-01-09       Impact factor: 3.445

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.